Enliven Therapeutics, Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

20.68

-0.84 (-3.90%)

Jun 27, 2025, 4:00 PM - Market closed

Enliven Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 27, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,220	1,099	570	-	-	-
Market Cap Growth	32.60%	92.74%	-	-	-	-
Enterprise Value	931	808	307	-	-	-
Last Close Price	21.57	22.50	13.84	-	-	-
PB Ratio	3.67	3.55	2.32	-	-	-
P/TBV Ratio	4.23	3.55	2.32	-	-	-
Debt / Equity Ratio	0.00	-	0.00	0.01	0.00	0.00
Quick Ratio	20.72	19.70	9.78	7.78	19.13	88.20
Current Ratio	21.07	19.99	10.28	8.00	19.24	88.35
Return on Equity (ROE)	-31.30%	-32.04%	-44.90%	-41.90%	-20.94%	-
Return on Assets (ROA)	-21.36%	-21.87%	-28.94%	-24.66%	-12.67%	-
Return on Capital (ROIC)	-22.71%	-23.50%	-32.14%	-26.86%	-13.08%	-
Earnings Yield	-7.77%	-8.10%	-12.55%	-	-	-
FCF Yield	-6.07%	-6.66%	-10.77%	-	-	-
Buyback Yield / Dilution	-18.45%	-32.43%	-1037.74%	60.02%	-56.70%	-

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q